AZACITIDINE

作品数:13被引量:35H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:邓程新李益清马丽萍更多>>
相关机构:中山大学孙逸仙纪念医院北京协和医学院广东省人民医院更多>>
相关期刊:《China Medical Abstracts(Internal Medicine)》《World Journal of Gastroenterology》《Signal Transduction and Targeted Therapy》《Journal of Cancer Metastasis and Treatment》更多>>
相关基金:国家自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Azacitidine maintenance therapy for blastic plasmacytoid dendritic cell neoplasm allograft: A case report
《World Journal of Clinical Cases》2024年第1期136-141,共6页Li-Li Tao Hui-Ting Wen Zi-Yi Wang Juan Cheng Li Zhao 
BACKGROUND Blastic plasmacytoid dendritic cell neoplasm(BPDCN)is a rare,highly invasive malignant neoplasm.There is no universally accepted standard of care because of its rarity and the dearth of prospective research...
关键词:Blastic plasmacytoid dendritic cell neoplasm AZACITIDINE Allogeneic hematopoietic stem cell transplantation Maintenance therapy Case report 
Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy被引量:1
《Signal Transduction and Targeted Therapy》2023年第6期2451-2454,共4页Leiming Xia Wanlu Tian Yiming Zhao Lingling Jiang Wei Qian Lei Jiang Ling Ge Jianjun Li Fengbo Jin Mingzhen Yang 
Dear Editor,Acute Myeloid Leukemia(AML)patients are often found ineligible for aggressive standard chemotherapy in clinic because of old age and poor conditions.Current evidences suggest that targeted combination ther...
关键词:PATIENTS CHEMOTHERAPY ACUTE 
Clinical Efficacy of Decitabine/Azacitidine in Combination with HAG in the Treatment of Elderly Patients with Acute Myeloid Leukemia
《Journal of Clinical and Nursing Research》2022年第4期50-55,共6页Lan Li Weihua Zhang 
This study was conducted to investigate the clinical effect of combining decitabine/azacitidine with HAG in the treatment of single elderly patients with acute myeloid leukemia.Patients in Shaanxi Provincial People’s...
关键词:DECITABINE AZACITIDINE HAG Elderly patients with acute myeloid leukaemia 
Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia:a single-institution experience
《China Medical Abstracts(Internal Medicine)》2022年第2期120-121,共2页YU Wenjing 
Objective To explore the safety and short-term efficacy of venetoclax combined with azacitidine (Ven+AZA) in previously untreated patients unfit for standard chemotherapy and patients with relapsed/refractory (R/R) ac...
关键词:ACUTE CHEMOTHERAPY MYELOID 
Venetoclax resistance:mechanistic insights and future strategies被引量:2
《Cancer Drug Resistance》2022年第2期380-400,共21页Faustine Ong Kunhwa Kim Marina Y.Konopleva 
Acute myeloid leukemia(AML)is historically associated with poor prognosis,especially in older AML patients unfit for intensive chemotherapy.The development of Venetoclax,a potent oral BH3(BCL-2 homology domain 3)mimet...
关键词:Venetoclax acute myeloid leukemia hypomethylating agents AZACITIDINE DECITABINE RESISTANCE BCL2 protein human 
Del(5q) and inv(3) in myelodysplastic syndrome: A rare case report
《World Journal of Clinical Cases》2022年第11期3601-3608,共8页Hai-Ping Liang Xing-Chun Luo Ya-Li Zhang Bei Liu 
BACKGROUND Del(5q)is the most common molecular event in myelodysplastic syndrome(MDS),accounting for 10%-15%of cases.Inv(3)is an adverse cytogenetic abnormality observed in less than 1%of MDS patients.Few studies have...
关键词:Myelodysplastic syndrome Del(5q) Inv(3) LENALIDOMIDE AZACITIDINE Case report 
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia被引量:5
《四川生理科学杂志》2022年第3期415-415,共1页Pau Montesinos 
Conclusions:Ivosidenib and azacitidine showed significant clinical benefit as compared with placebo and azacitidine in this difficult-to-treat population.Febrile neutropenia and infections were less frequent in the iv...
关键词:IDH1 frequent population. 
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia被引量:4
《Cancer Drug Resistance》2021年第1期125-142,共18页Antoine N.Saliba August J.John Scott H.Kaufmann 
Despite the success of the combination of venetoclax with the hypomethylating agents(HMA)decitabine or azacitidine in inducing remission in older,previously untreated patients with acute myeloid leukemia(AML),resistan...
关键词:Venetoclax hypomethylating agents RESISTANCE acute myeloid leukemia AZACITIDINE DECITABINE 
Azacitidine decreases reactive oxygen species production in peripheral white blood cells:A case report被引量:2
《World Journal of Clinical Cases》2020年第22期5657-5662,共6页Hidekazu Hasunuma Naomi Shimizu Hiromitsu Yokota Ichiro Tatsuno 
BACKGROUND In myelodysplastic syndrome(MDS),oxidative stress is closely related to iron overload and DNA damage.A recent study suggested the possibility that increased oxidative stress causes not only iron overload bu...
关键词:Myelodysplastic syndrome Reactive oxygen species Diacron-reactive oxygen metabolites FERRITIN AZACITIDINE Case report 
Determination of Azacitidine by Spectrophotometric Method
《Open Journal of Medicinal Chemistry》2018年第2期15-21,共7页B. Ramachandra N. Venkatasubba Naidu 
Simple, selective and sensitive spectrophotometric method has been developed for the determination of Azacitidine in pharmaceutical formulations and blood with MBTH (3-methyl-2-benzothiazolone hydrazone hydrochloride)...
关键词:UV-VISIBLE SPECTROPHOTOMETRY AZACITIDINE BLOOD Sample MBTH/FeCl3 and OXIDATIVE Coupling Reaction 
检索报告 对象比较 聚类工具 使用帮助 返回顶部